Can a pill prevent HIV? iPrEx, a large international study led by Gladstone Investigator Dr. Robert Grant, said “yes.” The study provided the first evidence that HIV infection can be prevented by a single daily tablet that combines two antiviral drugs. Time named the iPrEx study the #1 medical breakthrough of 2010.
Dr. Grant will describe these exciting findings and explain how they suggest a new strategy to help stop the HIV pandemic. The lecture will be followed by a panel discussion with leading experts in HIV prevention and a drag performance by Garza, a classically trained ballet dancer, choreographer, and LGBT activist.
Dr. Robert Grant MD, MPH is the Gladstone Institute of Virology and Immunology Associate Professor of Medicine at University of California, San Francisco.
Gladstone Institute investigator Robert Grant presents encouraging results from the iPrEx study of Truvada, a pill for prevention of HIV infection. With findings of significantly reduced infections as compared to the placebo group, Grant announces the next phase will expand the study group.